IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aptevo Therapeutics Inc

CUSIP: 03835L405 | 17 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Birchview Capital, LP10,000
0.0% of portfolio›$30.5K
StyleTurnoverLocationFiled
Birchview Capital, LP
10,000$30.5K0.0%CoreHighBurlington, VT2025-08-14